Open AccessCURRENT APPROACH TO DEVELOPMENT OF BIOSIMILAR PRODUCTS CONTAINING MONOCLONAL ANTIBODIES AS AN ACTIVE SUBSTANCE – NON-CLINICAL AND CLINICAL STUDIES OF THE FIRST RUSSIAN RITUXIMAB BIOSIMILAR, ACELLBIA®
Author(s) -
С М Алексеев,
Kamil Kaplanov,
Р. А. Иванов,
Е. В. Черняева
Publication year - 2015
Publication title -
issledovaniâ i praktika v medicine
Language(s) - English
Resource type - Journals
eISSN - 2410-1893
pISSN - 2409-2231
DOI - 10.17709/2409-2231-2015-2-1-8-12
Subject(s) - biosimilar , medicine , rituximab , pharmacodynamics , pharmacokinetics , lymphoma , follicular lymphoma , gastroenterology , oncology , immunogenicity , urology , antibody , immunology